ATN 110 Chemistry: Test and Results Dataset in Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States

Data from Chemistry Results Form R3 [CRF 11]
Study Description
A pre-exposure prophylaxis (PrEP) demonstration project and Phase II safety study to obtain additional data on the safety of emtricitabine/tenofovir (FTC/TDF (Truvada®)) and evaluate patterns of use, rates of adherence, and patterns of sexual risk behavior among YMSM (inclusive of transgender women) who were provided with open label FTC/TDF and information on the safety and efficacy of PrEP from prior studies. This project also explored the feasibility and acceptability of implementing two different efficacious risk reduction interventions prior to provision of PrEP - Many Men, Many Voices (3MV) and Personalized Cognitive Counseling (PCC).
HIV-1 uninfected young men who have sex with men, ages 18-22 years

化学检测结果表R3的数据[病例报告表11（CRF 11）]
研究概况
本研究为一项暴露前预防（Pre-exposure Prophylaxis，PrEP）示范项目与II期安全性研究，旨在获取恩曲他滨/替诺福韦（emtricitabine/tenofovir，FTC/TDF（Truvada®））的额外安全性数据，并评估在开放标签给予FTC/TDF、并提供既往研究中PrEP安全性与有效性信息的男男性行为青年（Young Men who Have Sex with Men，YMSM，含跨性别女性）群体中的用药模式、依从率及性风险行为模式。本项目同时探索了在提供PrEP前实施两种高效风险降低干预措施的可行性与可接受性——「众男众声（3MV，Many Men, Many Voices）」与个性化认知咨询（Personalized Cognitive Counseling，PCC）。
研究对象：未感染HIV-1的18至22岁男男性行为青年。